Samsung Biologics receives additional ISO 22301 certification under Business Continuity Excellence.

M2 EQUITYBITES-May 19, 2020-Samsung Biologics receives additional ISO 22301 certification under Business Continuity Excellence

(C)2020 M2 COMMUNICATIONS http://www.m2.com

Biologics company Samsung Biologics (207940.KS) said on Monday that it has achieved an ISO22301 certification for additional business operations, including Plant 1, Plant 2, Plant 3, bio-testing, QC services, small scale operations to ensure client satisfaction and operational excellence through its business continuity management system (BCMS).

The ISO22301 certification, the international standard for business continuity management published by the International Organization for Standardization, now allows clients to seek a...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT